NO138597C - Analogifremgangsmaate til fremstilling av terapeutisk aktive, klorerte derivater av 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropan - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive, klorerte derivater av 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropan

Info

Publication number
NO138597C
NO138597C NO734545A NO454573A NO138597C NO 138597 C NO138597 C NO 138597C NO 734545 A NO734545 A NO 734545A NO 454573 A NO454573 A NO 454573A NO 138597 C NO138597 C NO 138597C
Authority
NO
Norway
Prior art keywords
diarylcyclopropane
delta2
analogical
imidazolinyl
procedures
Prior art date
Application number
NO734545A
Other languages
English (en)
Norwegian (no)
Other versions
NO138597B (no
Inventor
Jean-Claude Cognacq
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB577473*[A external-priority patent/GB1417174A/en
Application filed by Hexachimie filed Critical Hexachimie
Publication of NO138597B publication Critical patent/NO138597B/no
Publication of NO138597C publication Critical patent/NO138597C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO734545A 1972-11-30 1973-11-28 Analogifremgangsmaate til fremstilling av terapeutisk aktive, klorerte derivater av 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropan NO138597C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5527872 1972-11-30
GB577473*[A GB1417174A (en) 1972-11-30 1973-02-06 1-2-delta2-imidazolinyl-2,2-diarylcoclopropanes

Publications (2)

Publication Number Publication Date
NO138597B NO138597B (no) 1978-06-26
NO138597C true NO138597C (no) 1978-10-04

Family

ID=26240140

Family Applications (1)

Application Number Title Priority Date Filing Date
NO734545A NO138597C (no) 1972-11-30 1973-11-28 Analogifremgangsmaate til fremstilling av terapeutisk aktive, klorerte derivater av 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropan

Country Status (17)

Country Link
US (1) US3905993A (https=)
JP (1) JPS504072A (https=)
AR (1) AR203020A1 (https=)
AT (1) AT329553B (https=)
CA (1) CA1018176A (https=)
CH (1) CH583200A5 (https=)
CS (1) CS181258B2 (https=)
DD (1) DD107687A5 (https=)
DE (1) DE2359795A1 (https=)
DK (1) DK132173C (https=)
ES (1) ES421017A1 (https=)
FR (1) FR2208664B1 (https=)
HU (1) HU167291B (https=)
NL (1) NL7316484A (https=)
NO (1) NO138597C (https=)
SE (1) SE404797B (https=)
SU (1) SU489328A3 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR116472A1 (es) 2018-09-28 2021-05-12 Celltrion Inc Sal de ácido quiral de (-)-cibenzolina, proceso para la preparación de su sal enantioméricamente pura y composición farmacéutica que la comprende; forma cristalina de la misma, un método para su obtención y una composición farmacéutica que comprende a dicha forma cristalina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH283583A (de) * 1949-02-24 1952-06-15 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung eines neuen Imidazolinabkömmlings.

Also Published As

Publication number Publication date
HU167291B (https=) 1975-09-27
SE404797B (sv) 1978-10-30
ATA996173A (de) 1975-08-15
FR2208664A1 (https=) 1974-06-28
FR2208664B1 (https=) 1976-10-08
DD107687A5 (https=) 1974-08-12
NO138597B (no) 1978-06-26
CS181258B2 (en) 1978-03-31
AR203020A1 (es) 1975-08-08
AT329553B (de) 1976-05-25
DK132173C (da) 1976-03-29
JPS504072A (https=) 1975-01-16
SU489328A3 (ru) 1975-10-25
AU6297273A (en) 1975-05-29
ES421017A1 (es) 1976-07-16
DE2359795A1 (de) 1974-06-06
NL7316484A (https=) 1974-06-04
DK132173B (da) 1975-11-03
CH583200A5 (https=) 1976-12-31
US3905993A (en) 1975-09-16
CA1018176A (fr) 1977-09-27

Similar Documents

Publication Publication Date Title
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO136094C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater.
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO138532C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(4-fenoksy-fenyl)-1,3,5-triazin-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO137966C (no) Analogifremgangsmaate til fremstilling av antibakterielt virksomme 5-oksopyrido-(2,3-d)-pyrimidinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO137550C (no) Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
SE398120B (sv) Forfarande for framstellning av 3-(1-piperazinylalkyl)-2,4-kinazolindionforeningar
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO136840C (no) Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin
NO138568C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 21-(bea-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethyl-aminobenzyliden)-triamcinolon
SE404798B (sv) Forfarande for framstellning av terapeutiskt verksamma 1-(2-deltaŸ2-imidazolinyl)-2,2-difenylcyklopropaner
NO136574C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater.
NO138597C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, klorerte derivater av 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropan
NO138659C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive, nye 3,5-disubstituerte triazolforbindelser